First, hyperinsulinemia occurring during insulin therapy might induce sympathetic nervous system stimulation and consequently increase heart rate and QTc, which are well-known risk factors for ventricular arrhythmias (47–49). This evidence concerns the gene INS and Hyperinsulinemia.